Asieris and ReviR Therapeutics Work Together to Develop Novel Oncology Treatments
Image Source:- >> | Content Source:- >> Asieris Pharmaceuticals and ReviR Therapeutics have agreed to a research collaboration and option-to-license arrangement to develop new oncology treatments. The partnership uses ReviR’s RNA-targeted technologies to discover and develop novel, cutting-edge therapies for genitourinary (GU) tumors and other significant associated disorders. As...